Grail Stock Has Soared 180% in 6 Months. Here's Why the Stock Has More Room to Run.

A positive FDA vote is driving the recent surge in the multi-cancer early detection (MCED) test company.

CryptoAlerta — análise de criptomoedas e mercado em tempo real